The present application relates to the technical field of veterinary biological products, in particular to application of oridonin in preparation of poultry
vaccine adjuvant. The poultry
vaccine adjuvant is composed of oridonin,
solvent and buffer. Experiments prove that after mixing the poultry
vaccine adjuvant with poultry
inactivated vaccine (such as
Newcastle disease vaccine) for immunization, the humoral immune level of poultry can be significantly improved (HI
titer of 21d after the second immunization is increased by more than 1.5 log2), and the
secretion level of specific IgY (
systemic immunity) and IgA (
mucosal immunity) in serum can be extremely significantly up-regulated, and the high level of
antibody is maintained for more than 4 weeks longer than that of the conventional vaccine group. Compared with commercial
adjuvant ISA 201, the present application has better immune enhancement activity, high safety, no adverse reaction at
injection site, and wide clinical application prospect.